Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Patient-centricity at the heart of innovation

Discover the patient-driven design behind YpsoDose, our wearable patch injector for large-volume biologics. Learn how human factors shaped its intuitive, comfortable, and reliable use—simplifying self-injection for patients at home.

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.

High performance in high-dose drug delivery

Discover how Ypsomed’s advanced delivery devices, including YpsoMate and YpsoDose, empower high-dose drug delivery. From viscosities to volumes, our innovative platforms transform patient care and enable pharmaceutical success. Explore the solutions …

A fresh look at how patients interact with pen injectors

How do patients handle pen injectors, and what forces do they apply during use? How can these findings shape the design of future devices to improve comfort and usability, especially for those with dexterity challenges?

Subcutaneous drug delivery: Adapting to high-viscosity, large-volume demands

Explore how Ypsomed is innovating subcutaneous drug delivery to meet the demands of high-viscosity and large-volume formulations.

Reduced injection time and effort for enhanced patient comfort

Discover the latest innovation from Ypsomed: the YpsoMate 2.25 autoinjector, now configurated with an 8 mm needle. Designed to enhance patient comfort and injection efficiency, this new option continues our commitment to improving patient experiences …

Clicking sounds of autoinjectors: A method to assess the audibility considering the spectrum of human hearing

To make sure people with visual and hearing impairments can use the YpsoMate autoinjectors without limitations, the devices are tested at METAS regarding the effectiveness of their acoustic signals.

Digital Health meets patient needs – the power of user testing

Are you looking for digital health solutions that are adopted by patients at the start of therapy and keeps them on the therapy for as long as it is necessary? Dive into the latest insights from Ypsomeds’ Human Factors studies on digital health …

How diabesity is shaping the world of self-injection devices

Innovative peptide hormone molecules for treating diabetes and obesity are fundamentally changing the market for self-injection systems and the demand for pens and autoinjectors continues to increase.
Load more